← Back to Patent Explorer
US4096247A Expired / Lapsed US ⏱️ 0.0 years remaining

Gold thio glucopyranoside compounds and method of use

Assignee: GlaxoSmithKline LLC
•
Filing: 1977-02-16
•
Granted: 1978-06-20
•
Expires: 1997-02-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new series of lower alkyl ethers of S-tri-lower-alkylphosphinegold 1-thio-β-D-glucopyranoside has been prepared and found to have anti-arthritic activity and, in particular, are of use in the treatment of rheumatoid arthritis.

Inventors

  • 👤 Ivan Lantos

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 05:21
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/02; C07H15/04; A; A61; A61P; A61P29/00; C07H23/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 21 words
A chemical compound of the formula: ##STR2## in which: R and R 1 are each respectively lower alkyl of 1-4 carbons.
Claim 2
Dependent Claim 21 words
A chemical compound of the formula: ##STR2## in which: R and R 1 are each respectively lower alkyl of 1-4 carbons.
Claim 3
Dependent Claim 10 words
A compound of claim 1 in which R is methyl.
Claim 4
Dependent Claim 15 words
A compound of claim 1 in which R is methyl and R 1 is ethyl.
Claim 5
Dependent Claim 24 words
A pharmaceutical composition having anti-arthritic activity, in dosage unit form, comprising a pharmaceutical carrier and an effective amount of a compound of claim 1.
Claim 6
Dependent Claim 26 words
A method of producing anti-arthritic activity which comprises administering internally to a subject in need of treatment an effective amount of a compound of claim 1.
Claim 7
Dependent Claim 16 words
The method of claim 5 in which the compound is S-triethylphosphinegold(I) 2,3,4,6-tetra-O-methyl-1-thio-β-D-glucopyranoside which is administered orally.
Claim 8
Dependent Claim 22 words
The method of claim 6 in which the daily dosage is chosen from the range of from 1-12 mg of active ingredient.

References Cited (Backward Citations)

US3635945A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-06-19 1981-12-19 1982-06-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-06-19 1985-12-19 1986-06-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-06-19 1989-12-19 1990-06-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag